Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Molecules (Basel, Switzerland)|August 12, 2022
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma CellsAlexandr N Chernov, Tatiana A Filatenkova, Ruslan I Glushakov, et al.
Frontiers in Immunology|December 3, 2021
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 PatientsSergey G Shcherbak, Anna Yu Anisenkova, Sergei V Mosenko, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 17, 2012
Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumorsVladimir A Kulchitsky, Vladimir I Potkin, Yuri S Zubenko, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 2, 2019
New Derivatives of Bacteriopurpurin with Thiolated Au (I) Complexes: Dual Darkand Light Activated Antitumor PotencyMikhail A Grin, Sergei I Tikhonov, Albina S Petrova, et al.
Genes|March 25, 2022
Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian PatientsSergey G Shcherbak, Anton I Changalidi, Yury A Barbitoff, et al.
International Journal of Molecular Sciences|November 11, 2022
Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian PopulationOleg S Glotov, Kirill V Savostyanov, Tatyana S Nagornova, et al.
Frontiers in Genetics|November 2, 2020
Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of OutcomeAnton E Shikov, Yury A Barbitoff, Andrey S Glotov, et al.
Pageof 12